245 related articles for article (PubMed ID: 18803761)
1. Systemic humoral immunity to non-typeable Haemophilus influenzae.
King PT; Ngui J; Gunawardena D; Holmes PW; Farmer MW; Holdsworth SR
Clin Exp Immunol; 2008 Sep; 153(3):376-84. PubMed ID: 18803761
[TBL] [Abstract][Full Text] [Related]
2. Effect of interferon gamma and CD40 ligation on intracellular monocyte survival of nontypeable Haemophilus influenzae.
King P; Ngui J; Oppedisano F; Robins-Browne R; Holmes P; Holdsworth S
APMIS; 2008 Dec; 116(12):1043-9. PubMed ID: 19133006
[TBL] [Abstract][Full Text] [Related]
3. Adaptive immunity to nontypeable Haemophilus influenzae.
King PT; Hutchinson PE; Johnson PD; Holmes PW; Freezer NJ; Holdsworth SR
Am J Respir Crit Care Med; 2003 Feb; 167(4):587-92. PubMed ID: 12433671
[TBL] [Abstract][Full Text] [Related]
4. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats.
Akkoyunlu M; Forsgren A
APMIS; 1996 Oct; 104(10):709-17. PubMed ID: 8980621
[TBL] [Abstract][Full Text] [Related]
5. Antibody against Haemophilus influenzae protein D in patients with chronic conditions causing secondary immunodeficiency.
Hawdon N; Biman B; McCready W; Brigden M; Malik S; Vergidis D; Kisselgoff O; Ulanova M
Vaccine; 2012 Feb; 30(7):1235-8. PubMed ID: 22230580
[TBL] [Abstract][Full Text] [Related]
6. EF-Tu From Non-typeable
Thofte O; Su YC; Brant M; Littorin N; Duell BL; Alvarado V; Jalalvand F; Riesbeck K
Front Immunol; 2018; 9():2910. PubMed ID: 30619274
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae.
Sabirov A; Kodama S; Sabirova N; Mogi G; Suzuki M
Vaccine; 2004 Aug; 22(23-24):3112-21. PubMed ID: 15297063
[TBL] [Abstract][Full Text] [Related]
8. Antibody Binding and Complement-Mediated Killing of Invasive Haemophilus influenzae Isolates from Spain, Portugal, and the Netherlands.
Dudukina E; de Smit L; Verhagen GJA; van de Ende A; Marimón JM; Bajanca-Lavado P; Ardanuy C; Marti S; de Jonge MI; Langereis JD
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719154
[No Abstract] [Full Text] [Related]
9. Investigation of the potential of a 48 kDa protein as a vaccine candidate for infection against nontypable Haemophilus influenzae.
Webb DC; Otczyk DC; Cripps AW
Vaccine; 2007 May; 25(20):4012-9. PubMed ID: 17379362
[TBL] [Abstract][Full Text] [Related]
10. Sialic Acid Protects Nontypeable Haemophilus influenzae from Natural IgM and Promotes Survival in Murine Respiratory Tract.
Jackson MD; Wong SM; Akerley BJ
Infect Immun; 2021 May; 89(6):. PubMed ID: 33782153
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
Choi J; Nix EB; Gaultier GN; Cox AD; McCready W; Ulanova M
Vaccine; 2015 Apr; 33(16):1941-7. PubMed ID: 25738817
[TBL] [Abstract][Full Text] [Related]
12. Role of nontypeable Haemophilus influenzae in otitis media and chronic obstructive pulmonary disease.
Thanavala Y; Lugade AA
Adv Otorhinolaryngol; 2011; 72():170-5. PubMed ID: 21865721
[TBL] [Abstract][Full Text] [Related]
13. Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD.
Staples KJ; Taylor S; Thomas S; Leung S; Cox K; Pascal TG; Ostridge K; Welch L; Tuck AC; Clarke SC; Gorringe A; Wilkinson TM
PLoS One; 2016; 11(11):e0167250. PubMed ID: 27898728
[TBL] [Abstract][Full Text] [Related]
14. A role for intestinal T lymphocytes in bronchus mucosal immunity.
Wallace FJ; Cripps AW; Clancy RL; Husband AJ; Witt CS
Immunology; 1991 Sep; 74(1):68-73. PubMed ID: 1937575
[TBL] [Abstract][Full Text] [Related]
15. Naturally Acquired HMW1- and HMW2-Specific Serum Antibodies in Adults and Children Mediate Opsonophagocytic Killing of Nontypeable Haemophilus influenzae.
Winter LE; Barenkamp SJ
Clin Vaccine Immunol; 2016 Jan; 23(1):37-46. PubMed ID: 26512048
[TBL] [Abstract][Full Text] [Related]
16. An outbreak of infections caused by non-typeable Haemophilus influenzae in an extended care facility.
Van Dort M; Walden C; Walker ES; Reynolds SA; Levy F; Sarubbi FA
J Hosp Infect; 2007 May; 66(1):59-64. PubMed ID: 17379356
[TBL] [Abstract][Full Text] [Related]
17. Anti-EF-Tu IgG titers increase with age and may contribute to protection against the respiratory pathogen Haemophilus influenzae.
Thofte O; Kaur R; Su YC; Brant M; Rudin A; Hood D; Riesbeck K
Eur J Immunol; 2019 Mar; 49(3):490-499. PubMed ID: 30566236
[TBL] [Abstract][Full Text] [Related]
18. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
[TBL] [Abstract][Full Text] [Related]
19. [Study on the anti-NTHi infection of Hap recombinant protein in vivo].
Li WY; Wang BN; Zuo FQ; Zeng W; Feng F; Kuang Y; Jiang ZH; Li MY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):635-7, 641. PubMed ID: 20619085
[TBL] [Abstract][Full Text] [Related]
20. Development of a serological assay to predict antibody bactericidal activity against non-typeable Haemophilus influenzae.
Ercoli G; Baddal B; Alessandra G; Marchi S; Petracca R; Aricò B; Pizza M; Soriani M; Rossi-Paccani S
BMC Microbiol; 2015 Apr; 15():87. PubMed ID: 25927946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
